Unknown

Dataset Information

Effects of Exendin-4 on human adipose tissue inflammation and ECM remodelling.


ABSTRACT:

Background/objectives

Subjects with type-2 diabetes are typically obese with dysfunctional adipose tissue (AT). Glucagon-like peptide-1 (GLP-1) analogues are routinely used to improve glycaemia. Although, they also aid weight loss that improves AT function, their direct effect on AT function is unclear. To explore GLP-1 analogues' influence on human AT's cytokine and extracellular matrix (ECM) regulation, we therefore obtained and treated omental (OMAT) and subcutaneous (SCAT) AT samples with Exendin-4, an agonist of the GLP-1 receptor (GLP-1R).

Subjects/methods

OMAT and abdominal SCAT samples obtained from women during elective surgery at the Royal Devon & Exeter Hospital (UK) were treated with increasing doses of Exendin-4. Changes in RNA expression of adipokines, inflamma

SUBMITTER: Pastel E 

PROVIDER: S-EPMC5223133 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature